BeStock  
Stocks › Biotechnology › MLYS

Mineralys Therapeutics MLYS

US equityMarket cap rank #3034Biotechnology
$13.66 −$0.50 (-3.53%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.70 +0.29%
Open$13.81
Prev close$14.16
Day range$13.57 – $14.79
Volume1.35M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

MLYS Stock News

Headlines matching Mineralys Therapeutics or the MLYS ticker, most recent first.

  • Mineralys Therapeutics(MLYS.US) Director Sells US$3.01 Million in Common StockMarket news · 25 Sep 2026 · Direct mention
  • Form 144 | Mineralys Therapeutics(MLYS.US) Director Proposes to Sell 3.01 Million in Common StocksMarket news · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)TipRanks · 13 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $40 to $56Market news · 13 Aug 2026 · Direct mention
  • Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)TipRanks · 12 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $54Market news · 12 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 12 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $56Market news · 12 Aug 2026 · Direct mention
  • Mineralys Therapeutics, Inc. (MLYS) Gets a Buy From Wells FargoTipRanks · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 4 Jun 2026 · Direct mention
  • Goldman Sachs Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $42Market news · 4 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $42 to $56Market news · 8 May 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 8 May 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Context Therapeutics (CNTX) PositiveTipRanks · 7 May 2026 · Direct mention
  • TD Cowen Maintains Mineralys Therapeutics(MLYS.US) With Buy RatingMarket news · 7 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on MLYS.

Sign in to join the discussion.

Scroll to Top